Diagnostik und Therapie fetaler Rhythmusstörungen Teil 2 – Tachyarrhythmien und intrauterine antiarrhythmische Therapie

Lernziele

• Intrauterine Diagnose der Tachyarrhythmien

• Intrauterine antiarrhythmische Therapie

• References

• 1 Berg C, Gottschalk I, Geipel A et al. Diagnostik und Therapie fetaler Rhythmusstörungen Teil 1 – Methoden der Rhythmusdiagnostik, Extrasystolen und Bradyarrhythmien.. Ultraschall in Med 2013; 34: 114-130
• 2 Krapp M, Kohl T, Simpson JM et al. Review of diagnosis, treatment, and outcome of fetal atrial flutter compared with supraventricular tachycardia. Heart 2003; 89: 913-917
• 3 Api O, Carvalho JS. Fetal dysrhythmias. Best Pract Res Clin Obstet Gynaecol 2008; 22: 31-48
• 4 Griffin MP, Lake DE, Bissonette EA et al. Heart rate characteristics: novel physiomarkers to predict neonatal infection and death. Pediatrics 2005; 116: 1070-1074
• 5 Bergmans MG, Jonker GJ, Kock HC. Fetal supraventricular tachycardia. Review of the literature. Obstet Gynecol Surv 1985; 40: 61-68
• 6 Simpson JM, Sharland GK. Fetal tachycardias: management and outcome of 127 consecutive cases. Heart 1998; 79: 576-581
• 7 Krapp M, Baumann K, Axt-Fliedner R et al. Long-term outcome of children with prenatal diagnosed tachyarrhythmia. Ultraschall in Med 2011; 32: E175-E181
• 8 Miyake CY, del Nido PJ, Alexander ME et al. Cardiac tumors and associated arrhythmias in pediatric patients, with observations on surgical therapy for ventricular tachycardia. J Am Coll Cardiol 2011; 58: 1903-1909
• 9 Gembruch U. Fetal Tachyarrhythmia. In: Yagel S, Silverman N, Gembruch U, (eds) Fetal Cardiology. 2nd ed. New York: Informa Healthcare; 2009: 461-481
• 10 Gembruch U, Krapp M, Baumann P. Changes of venous blood flow velocity waveforms in fetuses with supraventricular tachycardia. Ultrasound Obstet Gynecol 1995; 5: 394-399
• 11 Krapp M, Baschat AA, Gembruch U et al. Flecainide in the intrauterine treatment of fetal supraventricular tachycardia. Ultrasound Obstet Gynecol 2002; 19: 158-164
• 12 Moodley S, Sanatani S, Potts JE et al. Postnatal outcome in patients with fetal tachycardia. Pediatr Cardiol 26.05.2012;
• 13 Jaeggi E, Fouron JC, Drblik SP. Fetal atrial flutter: diagnosis, clinical features, treatment, and outcome. J Pediatr 1998; 132: 335-339
• 14 Oudijk MA, Michon MM, Kleinman CS et al. Sotalol in the treatment of fetal dysrhythmias. Circulation 2000; 101: 2721-2726
• 15 Greene EA, Berul CI, Donofrio MT. Prenatal diagnosis of long QT syndrome: implications for delivery room and neonatal management. Cardiol Young 2012; Epub: 1-5
• 16 Simpson JM, Maxwell D, Rosenthal E et al. Fetal ventricular tachycardia secondary to long QT syndrome treated with maternal intravenous magnesium: case report and review of the literature. Ultrasound Obstet Gynecol 2009; 34: 475-480
• 17 Beinder E, Grancay T, Menéndez T et al. Fetal sinus bradycardia and the long QT syndrome. Am J Obstet Gynecol 2001; 185: 743-747
• 18 Jaeggi E, Fouron JC, Fournier A et al. Ventriculo-atrial time interval measured on M mode echocardiography: a determining element in diagnosis, treatment, and prognosis of fetal supraventricular tachycardia. Heart 1998; 79: 582-587
• 19 Wiegand G, Haber HP, Binder G et al. Tital page – ultrasound findings in newborns with amiodarone-induced hypothyroidism. Ultraschall in Med 2009; 30: 431-433
• 20 Jaeggi ET, Carvalho JS, De Groot E et al. Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study. Circulation 2011; 124: 1747-1754